Courtney Denton Dinardo, MD, on AML: Treatment Study Results

2018 ASCO Annual Meeting

Courtney Denton Dinardo, MD, of The University of Texas MD Anderson Cancer Center, discusses findings on the durable response with venetoclax in combination with decitabine or azacitidine in elderly patients with acute myeloid leukemia (Abstract 7010).

Aug

Today In Oncology

FDA Approves Pembrolizumab in Combination With Chemotherapy for First-Line Treatment of Metastatic Nonsquamous NSCLC

FDA Updates Prescribing Information for Pembrolizumab and Atezolizumab in Urothelial Carcinoma

Impact of Doctor-Patient Communication on Outcomes in Cancer Survivors

Cetuximab With Radiotherapy Found to Be Inferior to Standard Treatment in HPV-Positive Oropharyngeal Cancer

Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide in Pediatric Intermediate-Risk Rhabdomyosarcoma

;